BioMarin Pharmaceutical Inc.BMRNNASDAQ
Loading
Cash Flow PerformanceElevated
Percentile Rank100
3Y CAGR+181.0%
Studio
Year-over-Year Change

Free cash flow yield

3Y CAGR
+181.0%/yr
Annual compound
Percentile
P100
Near historical high
vs 3Y Ago
22.2x
Strong expansion
Streak
3 yr
Consecutive growthElevated
PeriodValueYoY Change
20256.36%+67.1%
20243.81%+1001.8%
20230.35%+20.6%
20220.29%-75.0%
20211.15%+448.7%
2020-0.33%+48.5%
2019-0.64%+22.5%
2018-0.83%+38.3%
2017-1.34%+51.1%
2016-2.74%-